CYT005-AllQbG10

BIOLOGICAL2 trials

Sponsors

Cytos Biotechnology AG

Conditions

Allergic AsthmaHypersensitivityPerennial Allergic Rhinoconjunctivitis

Phase 1

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

CompletedNCT00293904

Cytos Biotechnology AGHypersensitivity

Start: 2006-02-28End: 2007-02-28Target: 36Updated: 2007-09-20

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

CompletedNCT00652223

Cytos Biotechnology AGAllergic Asthma, Perennial Allergic Rhinoconjunctivitis

Start: 2005-03-31End: 2005-11-30Updated: 2008-04-09